nach oben

Current Cardiology Reports

Erschienen in:

07.05.2022 | COVID-19 | Public Health Policy (SS Virani and D Mahtta, Section Editors)

COVID’s Impact on Non-communicable Diseases: What We Do Not Know May Hurt Us

verfasst von: Karl Gordon Patti, Payal Kohli

Erschienen in: Current Cardiology Reports | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this review, we outline the impacts of the COVID-19 pandemic on non-communicable diseases around the world.

Recent Findings

The mechanisms of COVID-19’s impact on non-communicable diseases are both direct and indirect. The direct mechanisms include direct vascular and myocardial injury as well as pancreatic injury increasing incidence of new-onset diabetes. Indirect effects of the pandemic on non-communicable disease include delayed presentation for acute illness including STEMI and the impact of social distancing and quarantine policies on socialization, mental health, physical activity, and the downstream health impacts of inactivity and deconditioning.

Summary

International focus has been on disease variants, infection control and management, healthcare system, and resource utilization and infection incidence. However, the impact of this pandemic on non-communicable diseases has been largely overlooked but will manifest itself in the coming years to decades.

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/NEJMoa2002032.CrossRefPubMed

World Health Organization. WHO coronavirus (COVID-19) dashboard. Accessed January 7, 2022. https://covid19.who.int/.

Kohli P, Virani SS. Surfing the waves of the COVID-19 pandemic as a cardiovascular clinician. Circulation. 2020;142(2):98–100. https://doi.org/10.1161/circulationaha.120.047901.CrossRefPubMed

Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect. 2020;81(1):e84–6. https://doi.org/10.1016/j.jinf.2020.03.059.CrossRefPubMedPubMedCentral

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–9. https://doi.org/10.1001/jama.2020.6775.CrossRefPubMedPubMedCentral

World Health Organization. Cardiovascular diseases (CVDs). Accessed January 7, 2022. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

World Health Organization. Hypertension. WHO. Accessed January 7, 2022.

World Health Organization. Cardiovascular diseases. WHO. Accessed January 7, 2022.

World Health Organization. Diabetes. WHO. Accessed January 7, 2022.

10.

World Health Organization. Obesity. WHO. Accessed January 7, 2022.

11.

Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022. https://doi.org/10.1038/s41591-022-01689-3.CrossRefPubMedPubMedCentral

12.

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. Jun 2004;203(2):631–7. doi:https://doi.org/10.1002/path.1570.

13.

Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. https://doi.org/10.1126/science.abb2507.CrossRefPubMedPubMedCentral

14.

Zhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med. 2020;21(3):315–9. https://doi.org/10.31083/j.rcm.2020.03.126.CrossRefPubMed

15.

Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63(3):390–391. https://doi.org/10.1016/j.pcad.2020.03.001.

16.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3.

17.

Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11):1265. https://doi.org/10.1001/jamacardio.2020.3557.

18.

Petersen EL, Goßling A, Adam G, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur Heart J. 2022. https://doi.org/10.1093/eurheartj/ehab914.

19.

Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43(6):867–9. https://doi.org/10.1007/s40618-020-01236-2.CrossRefPubMedPubMedCentral

20.

Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021;13(1):95. https://doi.org/10.1186/s13098-021-00705-9.

21.

Barrett CE KA, Alvarez P, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years 1/7/22, Updated March 1, 2020–June 28, 2021. https://www.cdc.gov/mmwr/volumes/71/wr/mm7102e2.htm?s_cid=mm7102e2_w.

22.

Martínez-Colón GJ, Ratnasiri K, Chen H, et al. SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19. Cold Spring Harbor Laboratory; 2021.

23.

•• Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardio. 2021. https://doi.org/10.1038/s41569-021-00631-3. This review succinctly highlights the cardiovascular sequelae of COVID-19 survivors with a focus on differences in COVID severity.

24.

Excellence NIfHaC. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Updated November 11, 2021. Accessed January 7, 2022. https://www.nice.org.uk/guidance/ng188.

25.

New ICD-10-CM code for the 2019 novel coronavirus (COVID-19), December 3, 2020. Press Release. December 3, 2020, 2021. https://www.cdc.gov/nchs/data/icd/Announcement-New-ICD-code-for-coronavirus-19-508.pdf.

26.

Romero-Duarte A, Rivera-Izquierdo M, Guerrero-Fernandez de Alba I, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. May 20 2021;19(1):129. https://doi.org/10.1186/s12916-021-02003-7.

27.

Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32. https://doi.org/10.1016/S0140-6736(20)32656-8.CrossRefPubMedPubMedCentral

28.

•• Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. https://doi.org/10.1001/jama.2020.12603. This study of 143 patients outlines the persistence of symptoms following the acute phase COVID-19 illness.

29.

Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258–63. https://doi.org/10.1016/j.cmi.2020.09.052.CrossRefPubMed

30.

Maltezou HC, Pavli A, Tsakris A. Post-COVID syndrome: an insight on its pathogenesis. Vaccines (Basel). 2021;9(5). https://doi.org/10.3390/vaccines9050497.

31.

Welch C, Z KH-S, C AG, J ML, T AJ. Acute sarcopenia secondary to hospitalisation - an emerging condition affecting older adults. Aging Dis. 2018;9(1):151–164. https://doi.org/10.14336/AD.2017.0315.

32.

Brown CJ, Friedkin RJ, Inouye SK. Prevalence and outcomes of low mobility in hospitalized older patients. J Am Geriatr Soc. 2004;52(8):1263–70. https://doi.org/10.1111/j.1532-5415.2004.52354.x.CrossRefPubMed

33.

Semba RD, Ferrucci L, Sun K, et al. Oxidative stress is associated with greater mortality in older women living in the community. J Am Geriatr Soc. 2007;55(9):1421–5. https://doi.org/10.1111/j.1532-5415.2007.01308.x.CrossRefPubMedPubMedCentral

34.

Gelfand RA, Matthews DE, Bier DM, Sherwin RS. Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest. 1984;74(6):2238–48. https://doi.org/10.1172/JCI111650.CrossRefPubMedPubMedCentral

35.

Belli S, Balbi B, Prince I, et al. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. 2020;56(4):2002096. https://doi.org/10.1183/13993003.02096-2020.CrossRefPubMedPubMedCentral

36.

Welch C, Greig C, Masud T, Wilson D, Jackson TA. COVID-19 and acute sarcopenia. Aging Dis. 2020;11(6):1345–1351. https://doi.org/10.14336/AD.2020.1014.

37.

Paddon-Jones D, Sheffield-Moore M, Cree MG, et al. Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. J Clin Endocrinol Metab. 2006;91(12):4836–41. https://doi.org/10.1210/jc.2006-0651.CrossRefPubMed

38.

Group RC, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436.CrossRef

39.

Gibbons GH, Harold JG, Jessup M, Robertson RM, Oetgen WJ. The next steps in developing clinical practice guidelines for prevention. J Am Coll Cardiol. 2013;62(15):1399–400. https://doi.org/10.1016/j.jacc.2013.08.004.CrossRefPubMed

40.

Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899–911. https://doi.org/10.1016/S0140-6736(14)60685-1.

41.

Laffin LJ, Kaufman HW, Chen Z, et al. Rise in blood pressure observed among US adults during the COVID-19 pandemic. Circulation. 2022;145(3):235–7. https://doi.org/10.1161/circulationaha.121.057075.CrossRefPubMed

42.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective SC. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13. https://doi.org/10.1016/s0140-6736(02)11911-8.CrossRefPubMed

43.

Jabri A, Kalra A, Kumar A, et al. Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020;3(7): e2014780. https://doi.org/10.1001/jamanetworkopen.2020.14780.CrossRefPubMedPubMedCentral

44.

Tison GH, Avram R, Kuhar P, et al. Worldwide effect of COVID-19 on physical activity: a descriptive study. Ann Intern Med. 2020;173(9):767–70. https://doi.org/10.7326/m20-2665.CrossRefPubMed

45.

Grabowski DC, Mor V. Nursing home care in crisis in the wake of COVID-19. JAMA. 2020;324(1):23–4. https://doi.org/10.1001/jama.2020.8524.CrossRefPubMed

46.

Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014;64(5):472–81. https://doi.org/10.1016/j.jacc.2014.04.058.CrossRefPubMedPubMedCentral

47.

Stewart RAH, Held C, Hadziosmanovic N, et al. Physical activity and mortality in patients with stable coronary heart disease. J Am Coll Cardiol. 2017;70(14):1689–700. https://doi.org/10.1016/j.jacc.2017.08.017.CrossRefPubMed

48.

Gielen S, Laughlin MH, O’Conner C, Duncker DJ. Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis Jan-Feb. 2015;57(4):347–55. https://doi.org/10.1016/j.pcad.2014.10.001.CrossRef

49.

Pandey A, Patel M, Gao A, et al. Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study. Am Heart J. 2015;169(2):290–297 e1. https://doi.org/10.1016/j.ahj.2014.10.017.

50.

Young DR, Hivert MF, Alhassan S, et al. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation. 2016;134(13):e262–79. https://doi.org/10.1161/CIR.0000000000000440.CrossRefPubMed

51.

Nirmita Panchal RK, Cynthia Cox Follow, Rachel Garfield. The implications of COVID-19 for mental health and substance use. KFF. Accessed January 9, 2022. https://www.kff.org/coronavirus-covid-19/issue-brief/the-implications-of-covid-19-for-mental-health-and-substance-use/.

52.

Meyerholz DK, Edsen-Moore M, McGill J, Coleman RA, Cook RT, Legge KL. Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol. 2008;181(1):641–8. https://doi.org/10.4049/jimmunol.181.1.641.CrossRefPubMed

53.

Ornell F, Moura HF, Scherer JN, Pechansky F, Kessler FHP, von Diemen L. The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry Res. 2020;289: 113096. https://doi.org/10.1016/j.psychres.2020.113096.CrossRefPubMedPubMedCentral

54.

Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology. 2009;34(5):1198–208. https://doi.org/10.1038/npp.2008.78.CrossRefPubMed

55.

Hulin J, Brodie A, Stevens J, Mitchell C. Prevalence of respiratory conditions among people who use illicit opioids: a systematic review. Addiction. 2020;115(5):832–49. https://doi.org/10.1111/add.14870.CrossRefPubMed

56.

Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé). BMJ. 2019:l1451. https://doi.org/10.1136/bmj.l1451.

57.

Walker RE, Keane CR, Burke JG. Disparities and access to healthy food in the United States: a review of food deserts literature. Health Place. 2010;16(5):876–84. https://doi.org/10.1016/j.healthplace.2010.04.013.CrossRefPubMed

58.

Ghosh-Dastidar B, Cohen D, Hunter G, et al. Distance to store, food prices, and obesity in urban food deserts. Am J Prev Med. 2014;47(5):587–95. https://doi.org/10.1016/j.amepre.2014.07.005.CrossRefPubMedPubMedCentral

59.

Testa A, Jackson DB, Semenza DC, Vaughn MG. Food deserts and cardiovascular health among young adults. Public Health Nutr. 2021;24(1):117–24. https://doi.org/10.1017/s1368980020001536.CrossRefPubMed

60.

Poelman MP, Gillebaart M, Schlinkert C, et al. Eating behavior and food purchases during the COVID-19 lockdown: a cross-sectional study among adults in the Netherlands. Appetite. 2021;157:105002. https://doi.org/10.1016/j.appet.2020.105002.

61.

Raifman J, Bor J, Venkataramani A. Unemployment insurance and food insecurity among people who lost employment in the wake of COVID-19. Cold Spring Harbor Laboratory; 2020.

62.

Wolfson JA, Leung CW. Food Insecurity and COVID-19: Disparities in early effects for US adults. Nutrients. 2020;12(6):1648. https://doi.org/10.3390/nu12061648.CrossRefPubMedCentral

63.

Bin Zarah A, Enriquez-Marulanda J, Andrade JM. Relationship between dietary habits, food attitudes and food security status among adults living within the United States three months post-mandated quarantine: a cross-sectional study. Nutrients. 2020;12(11). https://doi.org/10.3390/nu12113468.

64.

Jain V, Al Rifai M, Lee MT, et al. Racial and geographic disparities in internet use in the U.S. among patients with hypertension or diabetes: implications for telehealth in the era of COVID-19. Diabetes Care. 2021;44(1):e15-e17. https://doi.org/10.2337/dc20-2016.

65.

Mahtta D, Daher M, Lee MT, Sayani S, Shishehbor M, Virani SS. Promise and perils of telehealth in the current era. Current Cardiology Reports. 2021;23(9). https://doi.org/10.1007/s11886-021-01544-w.

66.

• Gramegna M, Baldetti L, Beneduce A, et al. ST-segment–elevation myocardial infarction during COVID-19 pandemic. Circulation: Cardiovascular Interventions. 2020;13(8) https://doi.org/10.1161/circinterventions.120.009413. This small study highlights the experience of a regional public service healthcare hub in Italy and documents the impact of the COVID-19 pandemic on delayed presentation for STEMI.

67.

Watanabe Y, Miyachi H, Mozawa K, et al. Impact of the COVID-19 Pandemic on ST-elevation myocardial infarction from a single-center experience in Tokyo. Intern Med. 2021;60(23):3693–700. https://doi.org/10.2169/internalmedicine.8220-21.CrossRefPubMedPubMedCentral

68.

Aldujeli A, Hamadeh A, Briedis K, et al. Delays in presentation in patients with acute myocardial infarction during the COVID-19 pandemic. Cardiology Research. 2020;11(6):386–391. https://doi.org/10.14740/cr1175.

69.

Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst. 2014;8:25. https://doi.org/10.1186/1752-4458-8-25.CrossRefPubMedPubMedCentral

70.

Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444–8. https://doi.org/10.1126/science.abb2762.CrossRefPubMedPubMedCentral

71.

Hypertension ESoCCo. Position statement of the ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers. Updated March 13 2020. Accessed January 7, 2022. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang.

72.

Cardiology ACo. HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. Updated March 17 2020. Accessed January 7, 2022. https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19.

73.

Lindenfeld J, Zile MR, Desai AS, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021;398(10304):991–1001. https://doi.org/10.1016/S0140-6736(21)01754-2.CrossRefPubMed

Titel: COVID’s Impact on Non-communicable Diseases: What We Do Not Know May Hurt Us
verfasst von: Karl Gordon Patti
Payal Kohli
Publikationsdatum: 07.05.2022
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current Cardiology Reports / Ausgabe 7/2022
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-022-01704-6

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Treatment of Hypertension Among Non-Cardiac Hospitalized Patients

Alternative Nuclear Imaging Tools for Infection Imaging

How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?

Concomitant Surgical Left Atrial Appendage Occlusion: a Review

Exercise and Self-Management in Adults with Type 1 Diabetes